Drug Profile
Ciraparantag - AMAG Pharmaceuticals
Alternative Names: AMAG 977; Aripazine; PER 977Latest Information Update: 17 Mar 2022
Price :
$50
*
At a glance
- Originator Perosphere
- Class Amides; Coagulants; Piperazines; Small molecules
- Mechanism of Action Blood coagulation factor modulators; Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase II Haemorrhage
Most Recent Events
- 07 Mar 2022 Perosphere Pharmaceuticals initiates a phase II trial for Haemorrhage (In volunteers) in USA (IV) (NCT04593784)
- 04 Oct 2021 Pooled safety and efficacy data from two phase II trials in Haemorrhage released by Covis Pharma
- 05 Dec 2020 Pooled safety and efficacy data from two phase II trials in Haemorrhage presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem-2020)